Cargando…

Sequential administration of PD‑1 inhibitor and cetuximab causes pneumonia

Severe drug-induced lung injury (DLI) has been reported to be associated with sequential administration of osimertinib, a third-generation tyrosine kinase inhibitor, following a programmed cell death ligand 1 (PD-L1) inhibitor. However, the relationship of sequential treatment with an anti-epidermal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arai, Makoto, Abe, Mitsuhiro, Kitahara, Shinsuke, Sakuma, Noriko, Ohno, Izumi, Takahashi, Koji, Imai, Chiaki, Saeki, Hiromi, Suzuki, Takuji, Uzawa, Katsuhiro, Hanazawa, Toyoyuki, Takiguchi, Yuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236250/ https://www.ncbi.nlm.nih.gov/pubmed/37274471 http://dx.doi.org/10.3892/ol.2023.13874

Ejemplares similares

Radiotherapy plus cetuximab for locally advanced squamous cell head and neck cancer in patients with cisplatin-ineligible renal dysfunction: A retrospective study
por: Imai, Chiaki, et al.
Publicado: (2022)

Prognostic impact of the cross-sectional area of the erector spinae muscle in patients with pleuroparenchymal fibroelastosis
por: Kitahara, Shinsuke, et al.
Publicado: (2023)

Initial experience of radiotherapy plus cetuximab for Japanese head and neck cancer patients
por: Kurokawa, Marie, et al.
Publicado: (2015)

Identification of Antitumor miR-30e-5p Controlled Genes; Diagnostic and Prognostic Biomarkers for Head and Neck Squamous Cell Carcinoma
por: Minemura, Chikashi, et al.
Publicado: (2022)

Impact of miR-1/miR-133 Clustered miRNAs: PFN2 Facilitates Malignant Phenotypes in Head and Neck Squamous Cell Carcinoma
por: Asai, Shunichi, et al.
Publicado: (2022)

A retrospective comparison between digital to conventional drainage systems for secondary spontaneous pneumothorax related to diffuse interstitial lung disease
por: Shikano, Kohei, et al.
Publicado: (2023)

Molecular Pathogenesis of the Coronin Family: CORO2A Facilitates Migration and Invasion Abilities in Oral Squamous Cell Carcinoma
por: Kase-Kato, Ikuko, et al.
Publicado: (2021)

Identification of miR-199-5p and miR-199-3p Target Genes: Paxillin Facilities Cancer Cell Aggressiveness in Head and Neck Squamous Cell Carcinoma
por: Tanaka, Nozomi, et al.
Publicado: (2021)

Identification of Tumor Suppressive Genes Regulated by miR-31-5p and miR-31-3p in Head and Neck Squamous Cell Carcinoma
por: Oshima, Sachi, et al.
Publicado: (2021)

Genome-Wide Super-Enhancer-Based Analysis: Identification of Prognostic Genes in Oral Squamous Cell Carcinoma
por: Saito, Tomoaki, et al.
Publicado: (2022)

Identification of Tumor-Suppressive miR-30e-3p Targets: Involvement of SERPINE1 in the Molecular Pathogenesis of Head and Neck Squamous Cell Carcinoma
por: Minemura, Chikashi, et al.
Publicado: (2022)

Impact of Oncogenic Targets by Tumor-Suppressive miR-139-5p and miR-139-3p Regulation in Head and Neck Squamous Cell Carcinoma
por: Koma, Ayaka, et al.
Publicado: (2021)

Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma
por: Uzawa, Katsuhiro, et al.
Publicado: (2019)

Contrasting functions of the epithelial-stromal interaction 1 gene, in human oral and lung squamous cell cancers
por: Fan, Mengmeng, et al.
Publicado: (2022)

Current status of medical oncology in Japan and changes over the most recent 7-year period: results of a questionnaire sent to designated cancer care hospitals
por: Arai, Makoto, et al.
Publicado: (2021)

microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers
por: Nohata, Nijiro, et al.
Publicado: (2012)

Inhibition of integrin β1-mediated oncogenic signalling by the antitumor microRNA-29 family in head and neck squamous cell carcinoma
por: Koshizuka, Keiichi, et al.
Publicado: (2017)

Noteworthy Factors to Decide Therapeutic Strategy for Carcinoma ex Pleomorphic Adenoma of Parotid Gland: A Preliminary Study Statistical Analysis of 22 Cases from Single Institution
por: Mori, Kosei, et al.
Publicado: (2022)

Complement Factor H Is an Early Predictive Biomarker of the Therapeutic Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis
por: Yoneda, Riyo, et al.
Publicado: (2022)

Case of a Deep Neck Abscess During Treatment for COVID-19
por: Shiraishi, Kengo, et al.
Publicado: (2022)

Regulation of ITGA3 by the anti‐tumor miR‐199 family inhibits cancer cell migration and invasion in head and neck cancer
por: Koshizuka, Keiichi, et al.
Publicado: (2017)

Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs
por: Koshizuka, Keiichi, et al.
Publicado: (2017)

Intraperitoneal bleeding from the right gastroepiploic artery by endoscopic ultrasonography: a case report
por: Takahashi, Koji, et al.
Publicado: (2022)

Successful endoscopic retrieval of a migrated pancreatic stent using a basket catheter for peroral cholangioscopy through a biliary plastic stent pusher tube: a case report
por: Takahashi, Koji, et al.
Publicado: (2022)

Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma
por: Yamada, Yasutaka, et al.
Publicado: (2017)

Reflux-related Extraesophageal Symptoms Until Proven Otherwise: A Direct Measurement of Abnormal Proximal Exposure Based on Hypopharyngeal Multichannel Intraluminal Impedance as a Reliable Indicator for Successful Treatment Outcomes
por: Suzuki, Takeshi, et al.
Publicado: (2022)

Cardiac Arrest Induced by an Anaphylactic Reaction Associated With the First Dose of Cetuximab
por: Hane, Atsuya, et al.
Publicado: (2022)

A case of jugular bulb diverticulum causing pulsatile tinnitus
por: Fukumoto, Ichiro, et al.
Publicado: (2021)

Eribulin sensitizes oral squamous cell carcinoma cells to cetuximab via induction of mesenchymal-to-epithelial transition
por: Kitahara, Hiroko, et al.
Publicado: (2016)

A Case of Panitumumab-Responsive Metastatic Rectal Cancer Initially Refractory to Cetuximab
por: Kasagi, Yuta, et al.
Publicado: (2013)

Deep Phospho- and Phosphotyrosine Proteomics Identified Active Kinases and Phosphorylation Networks in Colorectal Cancer Cell Lines Resistant to Cetuximab
por: Abe, Yuichi, et al.
Publicado: (2017)

Feasibility of Biliary Drainage Using a Novel Integrated Biliary Stent and Nasobiliary Drainage Catheter System for Acute Cholangitis
por: Takahashi, Koji, et al.
Publicado: (2023)

Endoscopic Transpapillary Stenting for Malignant Hilar Biliary Stricture: Side-by-Side Placement versus Partial Stent-in-Stent Placement
por: Takahashi, Koji, et al.
Publicado: (2023)

Sequential histological findings and clinical response after carbon ion radiotherapy for unresectable sarcoma
por: Hayashi, Katsuhiro, et al.
Publicado: (2017)

Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Suzuki, Shinsuke, et al.
Publicado: (2021)

Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer
por: Hsu, Hung‐Chih, et al.
Publicado: (2019)

A case of refractory chronic subdural hematoma and internal carotid artery stenosis sequentially treated with surgical drainage, middle meningeal artery embolization, and carotid artery stenting
por: Imai, Ryotaro, et al.
Publicado: (2022)

Regulation of Oncogenic Targets by miR-99a-3p (Passenger Strand of miR-99a-Duplex) in Head and Neck Squamous Cell Carcinoma
por: Okada, Reona, et al.
Publicado: (2019)

Cetuximab in the management of colorectal cancer
por: Lenz, Heinz-Josef
Publicado: (2007)

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b1stphon6gmil4lcovmn5uh2u8